CLINICAL_TRIALS
trial_result
· 2015-05-05
Clinical Trial Update: Resveratrol's Effects on Inflammation and Oxidative Stress in Chronic Kidney Disease [Phase 3]
Summary
A Phase 3 trial evaluating resveratrol for inflammation and oxidative stress in chronic kidney disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Universidade Federal Fluminense | Conditions: Chronic Renal Insufficiency | Phase 3 | Status: COMPLETED